|
|
HUTCHMED (China) Ltd
HKSE •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 06/12/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeHKSE
Market Capitalization15,295 mln
Float508 mln
Earnings Date08/03/2026
P / E
4.39
Deeply undervalued
Beneish M-Score
-1.24
Manipulation likely
1-Year Forecast
33.12
Transformational upside
Key Fundamentals
EPS3.95
P/E4.39
ROE42.71
RPS4.91
ROIC-7.65
ROA28.70
EBITDA, mln4,006
EV / EBITDA1.38
EV / EBIT1.42
Revenue, mln4,287
EV / Revenue1.29
Financial Strength
Altman Z-Score4.24
Piotroski F-Score
4
/ 9
Beneish M-Score-1.24
1-Year Target Price33.12
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-1.59% |
50
/ 100
 |
| 1 Month |
-12.5% |
33
/ 100
 |
| 2 Months |
-18.04% |
34
/ 100
|
| 6 Months |
-21.45% |
33
/ 100
|
| 1 Year |
-26.75% |
23
/ 100
 |
|
| |
